Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-26

Clinical Trial Update: The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients [Phase 2, Phase 3]

View source ↗

Summary

This update summarizes the results of a Phase 2/Phase 3 trial evaluating leucine supplementation on body composition and muscle characteristics in elderly adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leucine (Leucine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED